Top Markets
#1 Status Status +26.96%
#2 Ontology Gas Ontology Gas +26.36%
#3 EXOD EXOD +22.08%
#4 ETHGas ETHGas +11.00%
#5 Fake World Assets Fake World Assets +10.37%
#6 aelf aelf +9.25%
#7 The Black Bull The Black Bull +8.43%
#8 Derive Derive +8.38%
#9 Gas Gas +8.36%
#10 Ontology Ontology +6.93%
Coin of the day
Status Status
Settings
Language
ENGLISH
Currency
USD
Theme
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Rank in Stocks #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Share Price
$20.01
Last synced: 2025-02-21
Market Cap
$48.36M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Singular Genomics Systems, Inc. (OMIC)

Category

Healthcare
Operating Margin for Singular Genomics Systems, Inc. (OMIC)
Operating Margin as of August 2026 TTM: -3,531.47%
According to Singular Genomics Systems, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -3,531.47%. At the end of 2022 the company had an Operating Margin of -12,220.52%.
Operating Margin history for Singular Genomics Systems, Inc. from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -3,531.47% 0.00%
2023 -3,531.47% -71.10%
2022 -12,220.52% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
31.28% -100.01%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
12.36% -100.00%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
0.00% -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
9.83% -100.00%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.